TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
ALGN

Align Technology Inc

Healthcare · Medical Instruments & Supplies

146.90$ -0.5% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Income Statement

Align Technology Inc (ALGN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 4,035 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ALGN
Line item 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
0.4 6.7 46 45 123 173 207 206 284 304 312 387 480 560 660 762 845 1,080 1,473 1,966 2,407 2,472 3,953 3,735 3,862 3,999 4,035
1.8 20 47 47 52 58 64 65 75 79 79 84 118 144 162 183 205 265 356 519 663 709 1,017 1,101 1,155 1,200 1,278
-1.3 -14 -0.4 -2.0 71 115 143 142 209 225 233 303 361 416 498 578 640 815 1,117 1,448 1,744 1,763 2,935 2,634 2,707 2,799 2,757
4.2 9.2 15 16 13 16 19 18 26 26 22 26 37 43 44 53 61 76 98 129 157 175 250 305 347 364 370
9.2 58 83 85 34 34 42 64 53 62 131 56 92 99 113 115 367 455 666 852 953 1,201 1,709 1,674 1,711 1,578 1,756
13 68 98 99 91 106 141 179 175 210 268 201 271 331 404 385 451 566 763 981 1,201 1,376 1,959 1,991 2,050 2,192 2,141
-15 -81 -99 -101 -20 9.8 2.4 -38 34 16 -34 103 90 86 94 194 189 249 354 467 542 387 976 643 643 608 616
0.0 0.0 0.0 0.2 0.4 0.3 0.1 0.3 0.3 0.0 0.1 0.0 0.1 2.1 1.1 3.2 2.5 6.4 11 0.0 148 8.2 36 5.4 2.1
-15 -89 -97 -99 -20 9.8 2.7 -34 37 17 -34 102 90 84 93 190 186 243 365 467 555 379 1,012 599 641 609 585
0.7 7.6 0.0 0.0 0.1 1.0 1.3 0.8 1.2 -63 -2.6 28 23 26 29 45 42 51 130 58 112 -1,397 240 237 196 188 175
-15 -89 -97 -99 -20 8.8 1.4 -35 36 80 -31 74 67 59 64 146 144 190 231 400 443 1,776 772 362 445 421 410
-14 -79 -68 -71 2.0 24 13 -27 47 30 -21 121 108 140 178 211 207 273 391 521 593 481 1,085 780 643 817 766

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?